Medicina clinica
Recurrent respiratory papillomatosis treated with combined erlotinib and celecoxib: A retrospective study.
Thais Lizondo López, Belén López García, Neus Basté, Isabel Vilaseca, Juan José Grau, Esther Carcelero San Martín
Published: 202610.1016/j.medcli.2025.107251
Abstract
INTRODUCTION: Recurrent respiratory papillomatosis is a rare benign airway disease caused by human papillomavirus, typically types 6 and 11. Management is often difficult due to high recurrence rates and lack of effective pharmacologic options. Recen…
Preview only. Read the full abstract at the source